That definitely is just market opportunity. Here's the
That definitely is just market opportunity. Here's the crazy part. Todos doesn't even need it to be successful
Given all the stuff that was approved or that people want to use...
- remdesivir, ivermectin, hydroxychloroquine, chloroquine, monoclonal antibody treatments – bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab)
That once worked, never worked, sorta works sometimes, it shows the market demand for just about anything that has a story attached to it, as people unfortunately are desperate.
I imagine once the story gets out about Tollovid, that it actually worked in two different studies and you can actually buy it today, the market might go nuts for Tollovid.
I can imagine sales potentially doubling each month for Tollovid. I'm sure Todos is thinking it. We'll see what happens. Then add into that what Gerald mentioned of Tollovid being the base and that they can add other things to. Also the potential for Tollovid one day being over the counter like Zicam or other pills. I posted Zicam sold in 2020 for over half a billion.
The positive data from this small trial today with the hardest setting (hospitalized) is a marketing gold mine for Tollovid. Everyone I know that I suggested taking Tollovid, I want back today and said, see the news today.
Now a question for Todos would be, how many bottles can you produce in 2022 and what are the margins. We know the margins of testing today which was great to hear.
Can they product 100M bottles?
100M @ $50 = $5B
But lets take 1M bottles that should be easily doable
1M @ $50 = Todos Market Cap
That isn't even the Max and that doesn't include any of the other revenue
The challenge for Todos is, they have so many avenues to go down, which ones to you pick first. I guess it depends on expansion of compassionate use and emergency use approval in a few countries. Each use/approval will have a greater acceleration of Tollovid sales in my view but what do I know. I'm the guy that bought at the HOD and close to LOD today.
1
Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
Top 5 Most Recently Viewed Articles
Hainan's Bold Steps Towards Global Trade Leadership Hainan's Free Trade Port (Hainan FTP) is reaching a pivotal moment with independent customs operations slated for implementation. This significant milestone is a central goal within the Master Plan for Building the Hainan Free Trade Port, representing both a fundamental achievement and a symbol of Hainan's evolving role...
Continue Reading
Constellation Energy Declares Quarterly Dividend The Board of Directors of Constellation Energy Corporation (Nasdaq: CEG) has recently made an important announcement regarding its financial health and commitment to its shareholders. They declared a quarterly dividend of $0.3525 per share on the company’s common stock. This dividend is to be paid to shareholders who are...
Continue Reading
Pure Ice Cream Expands Production Capacity Significantly Pure Ice Cream, famed for its popular brands like Kwality Ice Creams and Hershey's Ice Cream, has announced an important agreement that will enhance its production capabilities. This agreement involves a substantial investment of AED 80 million to establish a new manufacturing facility at Dubai Industrial City,...
Continue Reading
Understanding the Class Action Against Alto Neuroscience Alto Neuroscience, Inc. is currently facing a shareholder class action lawsuit that has drawn significant attention. This legal action arises from allegations that the company issued false and misleading statements regarding its product, ALTO-100, specifically related to its effectiveness in treating major...
Continue Reading
Understanding Meta Platforms and Its Market Position In today's fast-paced business environment, a detailed examination of companies like Meta Platforms (NASDAQ: META) is essential for investors and analysts alike. This article aims to provide a thorough comparative analysis of Meta alongside its key competitors within the Interactive Media & Services sector. By...
Continue Reading